z-logo
open-access-imgOpen Access
Guillain-Barré Syndrome After Receiving the First Dose of Oxford–AstraZeneca SARS-CoV-2 Vaccine
Author(s) -
Hossein Mozhdehipanah,
Shirin Mavandadi,
Sepideh Paybast
Publication year - 2022
Publication title -
acta medica iranica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.218
H-Index - 27
eISSN - 1735-9694
pISSN - 0044-6025
DOI - 10.18502/acta.v60i6.10045
Subject(s) - medicine , guillain barre syndrome , vaccination , covid-19 , weakness , pediatrics , immunology , surgery , disease , infectious disease (medical specialty)

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom